BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cyr KJ, Avaldi OM, Wikswo JP. Circadian hormone control in a human-on-a-chip: In vitro biology's ignored component? Exp Biol Med (Maywood) 2017;242:1714-31. [PMID: 29065796 DOI: 10.1177/1535370217732766] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Trapecar M. Multiorgan microphysiological systems as tools to interrogate interorgan crosstalk and complex diseases. FEBS Lett 2021. [PMID: 34923635 DOI: 10.1002/1873-3468.14260] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
2 Paudel KR, Jha SK, Allam VSRR, Prasher P, Gupta PK, Bhattacharjee R, Jha NK, Vishwas S, Singh SK, Shrestha J, Imran M, Panth N, Chellappan DK, Ebrahimi Warkiani M, Hansbro PM, Dua K. Recent Advances in Chronotherapy Targeting Respiratory Diseases. Pharmaceutics 2021;13:2008. [PMID: 34959290 DOI: 10.3390/pharmaceutics13122008] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
3 Malik M, Yang Y, Fathi P, Mahler GJ, Esch MB. Critical Considerations for the Design of Multi-Organ Microphysiological Systems (MPS). Front Cell Dev Biol 2021;9:721338. [PMID: 34568333 DOI: 10.3389/fcell.2021.721338] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
4 Dame K, Ribeiro AJ. Microengineered systems with iPSC-derived cardiac and hepatic cells to evaluate drug adverse effects. Exp Biol Med (Maywood) 2021;246:317-31. [PMID: 32938227 DOI: 10.1177/1535370220959598] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hawkins KG, Casolaro C, Brown JA, Edwards DA, Wikswo JP. The Microbiome and the Gut-Liver-Brain Axis for Central Nervous System Clinical Pharmacology: Challenges in Specifying and Integrating In Vitro and In Silico Models. Clin Pharmacol Ther 2020;108:929-48. [PMID: 32347548 DOI: 10.1002/cpt.1870] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
6 Stewart AG. Editorial overview: Engineering drug discovery technologies: clinical trial on-a-chip. Curr Opin Pharmacol 2019;48:vii-ix. [PMID: 31601474 DOI: 10.1016/j.coph.2019.09.013] [Reference Citation Analysis]
7 Lohasz C, Frey O, Bonanini F, Renggli K, Hierlemann A. Tubing-Free Microfluidic Microtissue Culture System Featuring Gradual, in vivo-Like Substance Exposure Profiles. Front Bioeng Biotechnol 2019;7:72. [PMID: 31001529 DOI: 10.3389/fbioe.2019.00072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
8 Watson DE, Hunziker R, Wikswo JP. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology. Exp Biol Med (Maywood) 2017;242:1559-72. [PMID: 29065799 DOI: 10.1177/1535370217732765] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]